,Date,Study,Study Link,Journal,Detection Method,Sample,Measure of Evidence (Sn & Sp),Speed of assay,FDA approval,Study Type,Added on,Study Population,Sample Text,Matches,Entry
,2020-06-30,Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus,https://doi.org/10.1016/j.jcv.2020.104374,Journal of Clinical Virology,,4.0,,,,Other,,"From 1 February 2020 onwards, SARS-CoV-2 detection was performed using RT-PCR assays targeting both the E and RdRp genes.","In the remaining four samples, the E, RdRp, N, ORF1b, ORF1ab and M gene results were negative, and these were deemed as false positive results.","Conclusions The AusDiagnostics assay is not specific for the detection SARS-CoV-2.

SARS-CoV-2 was detected in four additional samples by the AusDiagnostics assay.

Abstract Introduction There is limited data on the analytical performance of commercial nucleic acid tests (NATs) for laboratory confirmation of COVID-19 infection.",2020-05-12
,2020-05-08,Comparison of commercial RT-PCR diagnostic kits for COVID-19,https://doi.org/10.1016/j.jcv.2020.104412,Journal of Clinical Virology,,,,,,Other,,"Since the applied filter settings were not correct for reading the Seegene N-gene assay, we excluded these data from all of our analyses.",All of the kits included in our analysis were provided free of charge and none of the manufacturers were involved in the assessment and interpretation of the results.,We conclude that all RT-PCR kits assessed in this study may be used for routine diagnostics of COVID-19 in patients by experienced molecular diagnostic laboratories.,2020-05-12
,2020-05-06,Can computed tomography be a primary tool for COVID-19 detection? Evidence appraisal through meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200992/,Crit Care,,4.0,,,,Systematic review,,"Two investigators independently searched with the term of “novel coronavirus” or “coronavirus disease 2019” or “COVID-19” or “SARS-CoV-2” combined with “computed tomography” or “CT” on PubMed, Web of Science, Embase, Cochrane Library, and China Academic Journals Full-text Database (CJFD) till March 13, 2020.","Only 4 studies screened from 372 relevant articles were eligible [2, A total of 1286 patients in China were screened for COVID-19 using both RT-PCR and chest CT.",The detection of COVID-19 by traditional reverse-transcription diagnostic polymerase chain reaction (RT-PCR) tests is time-consuming and depends on the reliability of laboratory techniques.,2020-05-12
,2020-05-05,"Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration",https://doi.org/10.1101/2020.04.29.20082099,medrxiv,,755.0,,,,Other,,"Following the declaration of COVID-19 as a Public Health Emergency of International Concern on 30 th January 2020 16 , an application by Mologic, LSTM and SGUL to develop and manufacture rapid tests for COVID-19 was considered successful for funding from the Wellcome Trust and the Department for International Development (DFID) on the .",755 clinical samples from known COVID-19 patients and hospital negative controls were tested on Mologics IgG ELISA.,"SARS-CoV-2 detection was undertaken using the Altona Diagnostics RealStar®SARS-CoV-2 RT-PCR Kit (S and E genes).

These assays are sensitive and specific for SARS-CoV-2, but the scale of the COVID-19 pandemic has caused global shortages of essential reagents for testing, including those for sample collection, RNA extraction and pathogen detection.",2020-05-12
,2020-05-04,Practical recommendations for the perioperative management of patients with suspicion or serious infection by coronavirus SARS-CoV,https://doi.org/10.1016/j.redare.2020.03.002,Revista Española de Anestesiología y Reanimación (English Edition),,,,,,Other,,"Abstract In December 2019, the Wuhan Municipal Health and health Commission (Hubei Province, China) reported a series of cases of pneumonia of unknown aetiology.","In clinical trials in animals infected with MERS-CoV, both viraemia and lung damage were significantly reduced compared to controls A randomised controlled clinical trial is currently underway to evaluate its efficacy and safety in these patients.",Diagnostic confirmation of coronavirus is performed using molecular techniques (RT-PCR) and by comparing genomic sequencing with SARS-CoV-2.,2020-05-12
,2020-05-04,Self-collection: an appropriate alternative during the SARS-CoV-2 pandemic,https://doi.org/10.1016/j.jcv.2020.104417,Journal of Clinical Virology,,2.0,,,,Other,,"For a period of one week in March 2020, patients presenting for SARS-CoV-2 testing at dedicated COVID-19 collection rooms were offered participation in the study.",This was the case for two COVID-19 positive patients on SC who were only diagnosed by SCN and another only by SCT.,It may also be that PCR methods for viral detection are improving the sensitivity of a range of sample and collection methods as shown for a range of respiratory viruses but also Group A Streptococcal detection.,2020-05-12
,2020-04-30,Review and analysis of current responses to COVID-19 in Indonesia: Period of January to March 2020,https://doi.org/10.1016/j.pdisas.2020.100091,Progress in Disaster Science,,4.0,,,,Other,,"In late March 2020, the Indonesian Task Force for COVID-19 (Gugus Tugas Percepatan Penanganan COVID-19) issued the Guidelines for Medical Rapid Response and Public Health Aspects of COVID-19 in Indonesia.","A case of the Synod Assembly Council of Western Indonesian Churches (GPIB) on 26 February 29, 2020, had four participants tested positive for coronavirus.",Rapid detection tests (RDT) using kits based on antibody detections are known to be far less accurate than the PCR-based tests.,2020-04-24
,2020-04-30,World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19),https://doi.org/10.1016/j.ijsu.2020.02.034,International Journal of Surgery,,10566.0,,,,Other,, Received 3 February 2020; Received in revised form 17 February 2020; Accepted 24 February 2020,"The remaining 10,566 cases were identified in 72 countries including Japan, the US, and Australia.","Regarding diagnostic testing, US-based companies such as Co-Diagnostics and the Novacyt's molecular diagnostics division Primerdesign have launched COVID-2019 testing kits for use in the research setting .",2020-03-27
,2020-04-30,SnapShot: COVID-19,https://doi.org/10.1016/j.cell.2020.04.013,Cell,,,,,,Other,,"Blake Oberfeld, 1 Aditya Achanta, 1 Kendall Carpenter, 1 Pamela Chen, 1 Nicole M. Gilette, 1 Pinky Langat, 1 Jordan T. Said, 1 Abigail E. Schiff, 1,2, Allen S. Zhou, 1 Amy K. Barczak, 1,2 and Shiv Pillai In December 2019, several cases of pneumonia of unknown origin were reported in Wuhan, China.","Chest computed tomography (CT) scans of symptomatic patients are sensitive for detecting disease but nonspecific (CDC, 2020).","Reverse transcriptase-polymerase chain reaction of respiratory samples remains the gold standard for diagnosing COVID-19, though immunoassays, isothermal nucleic acid amplification tests, and CRISPR-based diagnostic tests are in development to facilitate rapid point-of-care testing and address global testing shortages (Pang et al., 2020) .",2020-05-12
,2020-04-30,Guide to Understanding the 2019 Novel Coronavirus,https://doi.org/10.1016/j.mayocp.2020.02.003,Mayo Clinic Proceedings,,35000.0,,,,Other,,"A cluster of cases of pneumonia caused by a novel coronavirus, COVID-19, was first reported in Wuhan in the Hubei province in China in late December 2019.","At the time of this report, there have been more than 35,000 confirmed cases of COVID-19, with more than 800 confirmed deaths (Figure) .","The currently available diagnostic tests for other coronaviruses (eg, FilmArray Respiratory Panel [BioFire Diagnostics]) do not detect the COVID-19.",2020-05-12
,2020-04-29,Tapestry: A Single-Round Smart Pooling Technique for COVID-19 Testing,https://doi.org/10.1101/2020.04.23.20077727,medrxiv,,2.0,,,,Modeling,,"The 16 × 40 matrix was tested for five different situations, corresponding to starting with zero positive samples, one positive sample (10 3 copies), two positive samples (10 3 copies each), three positive samples (two with 10 3 and one with 10 4 copies) or four positive samples (two with 10 3 , one with 10 4 and one with 10 5 copies).","The 16 × 40 matrix was tested for five different situations, corresponding to starting with zero positive samples, one positive sample (10 3 copies), two positive samples (10 3 copies each), three positive samples (two with 10 3 and one with 10 4 copies) or four positive samples (two with 10 3 , one with 10 4 and one with 10 5 copies).",The underlying molecular diagnostic test is any real-time RT-PCR diagnostic panel approved for the detection of the SARS-CoV-2 virus.,2020-05-12
,2020-04-29,"Decoding SARS-CoV-2 transmission, evolution and ramification on COVID-19 diagnosis, vaccine, and medicine",https://doi.org/,ArXiv,,6156.0,,,,Case series,,"In this work, we retrieve and genotype 6156 SARS-CoV-2 isolates from word as of April 24, 2020.","Based on the genotyping of 6156 genome samples collected up to April 24, 2020, we report that SARS-CoV-2 has had 4459 alarmingly mutations which can be clustered into five subtypes.",Real-time RT-PCR (rRT-PCR) is routinely used in the qualitative detection of nucleic acid from SARS-CoV-2 for diagnostic testing COVID-19 .,2020-05-01
,2020-04-29,The Diagnosis of Pandemic Coronavirus Pneumonia: A Review of Radiology Examination and Laboratory Test,https://doi.org/10.1016/j.jcv.2020.104396,Journal of Clinical Virology,,,,,,Other,,"In this review, we retrieved studies related to SARS, MERS, and COVID-19.","In COVID-19, 31% of lesion were unifocal, 69% were multifocal, 26% were unilobar, 74% were multilobar, 20% were unilateral, 80% were bilateral, 56% had lower lobe involvement, 82% were peripheral or subpleural, and 71% were central [37, 57] .","Compared with macroscopic morphological examinations, microcosmic etiological tests, including nucleic acid detection and serological detection, with high specificity, could serve as benchmarks for the laboratory detection of the virus In the past three decades, significant progress has been made in virus diagnostic testing, ranging from virus culture to rapid antigen detection, and recently to high-sensitivity NAAT, including PCR .",2020-05-01
,2020-04-25,Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19,https://doi.org/10.1016/j.mehy.2020.109786,Medical Hypotheses,,6.0,,,,Other,,"Although COVID-19 is generally thought to be milder compared to SARS and MERS-CoV, the full extent of the impact from COVID-19 remains pending.",LAMP exhibits increased sensitivity and specificity due to an exponential amplification feature that utilises 6 different target sequences simultaneously identified by separate distinct primers in the same reaction .,"and Prevention (CDCs) rapidly employed molecular assays for detection of COVID-19 in clinical samples These, and methods by other groups, mostly employed development of of quantitative RT-PCR characterized by rapid detection, high sensitivity and specificity, and are often described as a gold standard for virus detection .

A rapid, point-of-care diagnostic for the COVID-19 is urgently needed, which we propose to be the LAMP method of detection ( Table 1 ).",2020-05-01
,2020-04-23,Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories,https://doi.org/10.1016/j.cca.2020.04.023,Clinica Chimica Acta,,6.0,,,,Other,,The global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute 4 respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared by the World Health 5 Organization (WHO) in March 2020 .,The E_Sarbeco 102 We compared the C q values of simplex and multiplex rRT-PCR using six SARS-CoV-2 RNA-103 positive samples (Figure 1 ) and observed good correlation between the targets.,Abstract Background The detection of SARS-CoV-2 RNA by real-time reverse transcription–polymerase chain reaction (rRT-PCR) is used to confirm the clinical diagnosis of COVID-19 by molecular diagnostic laboratories.,2020-05-01
,2020-04-22,Coronavirus Disease (COVID-19) Pandemic: An Overview of Systematic Reviews,https://doi.org/10.1101/2020.04.16.20068213,medrxiv,,1063.0,,,,Systematic review,,"Methods: Nine databases (Medline, EMBASE, Cochrane Library, CINAHL, Web of Sciences, PDQ-Evidence, WHO's Global Research, LILACS and Epistemonikos) were searched from December 1, 2019 to March 24, 2020.","Our search retrieved 1,063 publications, of which 175 were duplicates.","Possible diagnostic approaches are RT-PCR, serological assays and point-of-care testing.

Sequencing of specimens and clinical diagnosis have been used as alternative diagnostic approaches.",2020-05-01
,2020-04-22,Real-time RT-PCR in COVID-19 detection: issues affecting the results,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189409/,Expert Rev Mol Diagn,,2.0,,,,Other,,"In the second patient, SARS-CoV-2 was detected in both URT and LRT specimens on day 14 of symptom onset.","Viral load kinetics of SARS-CoV-2 infection have been described in two patients in Korea, suggesting a different viral load kinetics from that of previously reported other coronavirus infections .","Along with the advancement in medical diagnosis, nucleic acid detection-based approaches have become a rapid and reliable technology for viral detection.

Among nucleic acid tests, the polymerase chain reaction (PCR) method is considered as the 'gold standard' for the detection of some viruses and is characterized by rapid detection, high sensitivity, and specificity.",2020-05-12
,2020-04-21,"COVID-19, a worldwide public health emergency",https://doi.org/10.1016/j.rceng.2020.03.001,Revista Clínica Española (English Edition),,25.0,,,,Other,,"© 2020 Elsevier España, S.L.U.",25 Children constitute a peculiar population with an immune system different from that of adults.,"33 The objectives of the diagnostic tests are to detect the common causes of early pneumonia, to support disease control activities and to work with reference laboratories that can perform pancoronavirus detection and direct sequencing.",2020-04-24
,2020-04-17,Optimizing RT-PCR detection of SARS-CoV-2 for developing countries using pool testing,https://doi.org/10.1101/2020.04.15.20067199,medrxiv,,4.0,,,,Other,,Nasopharyngeal samples in Universal Transport Media (UTM; Copan Diagnostics Inc) from patients COVID-19 positive and negative for SARS-CoV-2 were used.,Pools 13 to 26 included 4 negative samples and 1 positive sample with CT ranging from 16.6 to 36.1; pools 27 to 31 included 5 negative samples.,"The global shortage of reagents and kits for nucleic acid extraction and molecular detection of SARS-CoV-2, requires new cost-effective strategies for the diagnosis of suspected COVID-19 cases, especially in countries that need to increase detection capacity.",2020-04-24
,2020-04-14,First COVID-19 infections in the Philippines: a case report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154063/,Trop Med Health,,2.0,,,,Other,,"We describe the clinical and epidemiological aspects of the first two confirmed COVID-19 cases in the Philippines, both admitted to the national infectious disease referral hospital in Manila.","In this case report, we describe two cases: patient 1, the first confirmed COVID-19 case, and patient 2, the second confirmed case, even though the symptoms of patient 2 started first.","On January 27, the results were released of a commercially available respiratory pathogen multiplex real-time PCR for detection of pathogen genes on the NPS/OPS samples (FTD Respiratory pathogens 33, Fast Track Diagnostics) at the RITM Molecular Biology Laboratory.",2020-04-17
,2020-04-13,Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170415/,Ann Intern Med,,926.0,,,,Other,,We searched the PubMed database for articles on SARS–CoV-2 and diagnostics.,"As of 1 April 2020, the World Health Organization reported more than 926 000 cases in more than 195 countries, areas, or territories (3) .","Laboratory-based molecular assays for detecting SARS-CoV-2 in respiratory specimens are the current reference standard for COVID-19 diagnosis, but point-ofcare technologies and serologic immunoassays are rapidly emerging.

Although real-time reverse transcriptase polymerase chain reaction (RT-PCR)-based assays performed in the laboratory on respiratory specimens are the cornerstone of COVID-19 diagnostic testing, several novel or complementary diagnostic methods are being developed and evaluated .

However, point-of-care technologies and serologic immunoassays are rapidly emerging.",2020-04-24
,2020-04-13,"SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160911/,ACS Chem Neurosci,,3.0,,,,Other,,Epidemiological data should be collected to search for potential correlation between olfactory dysfunction and COVID-19 symptoms as well as severity.,Three major RNaseq transcriptome studies conducted in human and murine OE consistently suggest non-neuronal expression of ACE2.,"Currently, assays that are based on real-time RT-PCR technique are recommended for early detection of the virus.

Currently, assays that are based on realtime RT-PCR technique are recommended for early detection of the virus.",2020-04-24
,2020-04-10,Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients,https://doi.org/10.1016/j.jinf.2020.03.051,Journal of Infection,,39.0,,,,Other,,All samples were processed simultaneously at the Department of Laboratory Medicine of Zhongnan Hospital of Wuhan University.,In total 39 samples from 37 clinically diagnosed patients were included.,"The viral whole-genome sequencing and viral nucleic acid detection by real-time RT-PCR are regarded as standard diagnostic approaches.

Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients",2020-05-12
,2020-04-10,AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary,https://doi.org/10.1053/j.gastro.2020.04.012,Gastroenterology,,318.0,,,,Other,,"To this end, we have incorporated the general guidance and consensus statements from the British Society of Gastroenterology (BSG) 19 and from the International Organization for the Study of Inflammatory Bowel Disease (IOIBD).",The Wuhan IBD Center experience of their 318 patients demonstrates the benefit of this approach.,"Testing for SARS-CoV-2 is becoming more widespread, and point-of-care tests using sensitive nucleic acid detection or serologic antibodies are in development.",2020-04-17
,2020-04-09,"An overview of coronaviruses including the SARS-2 coronavirus – Molecular biology, epidemiology and clinical implications",https://doi.org/10.1016/j.cmrp.2020.04.001,Current Medicine Research and Practice,,813.0,,,,Retrospective observational,,"An extensive retrospective data of 1099 patients from 552 hospitals in mainland China from the onset of epidemic till January 29, 2020 deals with the demographic and clinical features of the patients from Wuhan and other non residents.","Various randomized clinical trials evaluating the efficacy of lopinavir/ritonavir (ChiCTR2000029308) and a new antiviral 19 This retrospective study enrolled 191 confirmed patients suffering from the disease from a cohort of 813 patients admitted in two different hospitals in Wuhan, 54 patients died in the hospital and 137 were discharged.","Serological assays to detection of SARS-CoV-2 are in the process of development.

However the test results by these rapid diagnostic kits need to be confirmed by RT-PCR for SARS-CoV-2.",2020-05-12
,2020-04-06,"Global epidemiology, pathogenesis, immune response, diagnosis, treatment, economic and psychological impact, challenges, and future prevention of COVID-19: A scoping review",https://doi.org/10.1101/2020.04.02.20051052,medrxiv,,5.0,,,,Other,,"Articles, reports, preprints, expert opinions, and information from websites conducted among human participants, published in English language, and briefly showing the data regarding the current outbreak COVID-19 were included.","additionally, sera from 5 patients of confirmed COVID-19 showed some cross-reactivity with SARS-CoV.",The following laboratory diagnostic techniques are used to detect COVID-19,2020-04-10
,2020-04-06,Clinical meanings of rapid serological assay in patients tested for SARS-Co2 RT-PCR,https://doi.org/10.1101/2020.04.03.20052183,medrxiv,,13.0,,,,Other,,"Oropharingeal swap samples were suddenly analyzed for SARS-CoV-2 rt-PCR in Laboratory of Molecular Epidemiology and Public Health of the Hygiene Unit of Policlinico Hospital (Bari, Italy), which is the Regional Reference Laboratory for the SARS-CoV-2 identification.","However, all 13 patients withVivaDiag TM positive test and negative RT-PCR result (6.8%) were positive for IgM while only 7 subjects resulted positive for IgG.",Background RT-PCR test for identifiction of viral nucleic acid is the current standard diagnostic method for the diagnosis of COVID-19 disease but technical reasons limit the utilization of this assay on large scale screenings.,2020-04-10
,2020-04-04,COVID-19: A promising cure for the global panic,https://doi.org/10.1016/j.scitotenv.2020.138277,Science of The Total Environment,,2494.0,,,,Other,,"The WHO, on February 11, 2020, officially named the viral disease COVID-19 Guarner, 2020) .","This was closely followed by the emergence of MERS-CoV at Saudi Arabia in 2012, which caused 858 deaths among the 2494 known infected cases (Zaki et al., 2012) .","During the SARS and MERS outbreaks effective diagnostic tools were developed for accurate detection.

Imaging techniques can also be utilized as a diagnostic method in COVID-19.",2020-04-10
,2020-03-31,"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China",https://doi.org/10.1016/j.micinf.2020.01.003,Microbes and Infection,,887.0,,,,Other,,"Abstract On 10 January 2020, a new coronavirus causing a pneumonia outbreak in Wuhan City in central China was denoted as 2019-nCoV by the World Health Organization (WHO).","As of 24 January 2020, there were 887 confirmed cases of 2019-nCoV infection, including 26 deaths, reported in China and other countries.","There are other molecular-based detection techniques in addition to RT-PCR and similar optimized detection techniques.

The following are some of the new coronavirus detection methods.

Currently, however, no diagnostic test kit is available for the detection of antibodies to 2019-nCoV.",2020-04-10
,2020-03-30,Diagnosing COVID-19: The Disease and Tools for Detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144809/,ACS Nano,,2.0,,,,Other,,"29, 30 According to the joint report by the World Health Organization (WHO) and China, 104 strains of the SARS-CoV-2 virus were isolated and sequenced using Illumina and Oxford nanopore sequencing from the end of December 2019 to mid-February 2020.","2 Patients were scanned using computed tomography (CT), which revealed varied opacities (denser, more profuse, and confluent) in comparison to images of healthy lungs.","According to the WHO, the immediate priority for COVID-19 diagnostics research is the development of nucleic acid and protein tests and detection at the point-of-care.

Other isothermal amplification techniques for COVID-19 detection are in development.

Other isothermal amplification techniques for COVID-19 detection are in development.62

Nucleic acid tests using isothermal amplification are currently in development for SARS-CoV-2 detection.

According to the WHO, the immediate priority for COVID-19 diagnostics research is the development of nucleic acid and protein tests and detection at the point-of-care.2 The longer-term priority is to integrate these tests into multiplex panels.",2020-04-17
,2020-03-27,Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients,https://doi.org/10.1016/j.cdtm.2020.02.003,Chronic Diseases and Translational Medicine,,76936.0,,,,Other,,"The disease caused by SARS-CoV-2 was named corona virus disease 2019 (COVID-19) by the World Health Organization (WHO) on February 12, 2020.","According to data released by the National Health Commission (NHC) of the People's Republic of China, as of 0:00 on February 22, there were a total of 76,936 confirmed infected cases, 22,888 cured cases, and 2442 deaths in China.",Diagnostic criteria: viral detection using RT-PCR is the common diagnostic criteria for both COVID-19 and CMV.,2020-05-12
,2020-03-23,Promising methods for detection of novel coronavirus SARS‐CoV‐2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169335/,PMC,,19.0,,,,Other,,"As of February 6, 2020, 19 other genome sequences of SARS-CoV-2 obtained by using Illumina or Nanopore platforms were also uploaded on GenBank by researchers in China, 3, 4 the United States, and Australia.","As of February 6, 2020, 19 other genome sequences of SARS-CoV-2 obtained by using Illumina or Nanopore platforms were also uploaded on GenBank by researchers in China, 3, 4 the United States, and Australia.","Antibody-based immunoassay techniques combined with different signal detection methods are also found to be typically rapid detection methods.

For instance, real-time RT-PCR is still the most widely used detection method in large hospitals, whereas antibody-based immunoassay techniques, paper-based biomolecular sensors, and the CRISPR-Cas system-based methods (e.g., SHER-LOCK) are still expected to be further developed as largescale screening methods that can even be used in the home settings.",2020-04-24
,2020-03-23,Can a Paper-Based Device Trace COVID-19 Sources with Wastewater-Based Epidemiology?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099676/,Environ Sci Technol,,158.0,,,,Other,,"About 158 111 confirmed cases and 5946 cumulative deaths (81 059 confirmed cases and 3204 cumulative deaths from China) have been reported around the globe as of March 15, 2020.","About 158 111 confirmed cases and 5946 cumulative deaths (81 059 confirmed cases and 3204 cumulative deaths from China) have been reported around the globe as of March 15, 2020.","Paper analytical devices enable multiplexed, sensitive assays that rival PCR laboratory assays and provide high-quality, fast precision diagnostics for pathogens.",2020-04-03
,2020-03-18,Point-of-Care RNA-Based Diagnostic Device for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151043/,Diagnostics (Basel),,145000.0,,,,Other,,A recent study conducted by Prof. Jinzhao Song at the University of Pennsylvania in mid-February of 2020 describes a novel closed-tube COVID-19 assay that includes pathogen nuclei acid amplification and detection .,"As of March 14, 2020, the death toll has exceeded 5400, and there have been 145,000 confirmed cases, causing not only a huge medical health burden but also tremendous economic losses worldwide .","Currently, there are two primary methods for diagnosing COVID-19: a lateral flow immunoassay, which is a common point-of-care (POC) diagnostic approach that detects antibodies against specific viruses (e.g., SARS-CoV-2) in patient samples; and a molecular-based assay.",2020-04-24
,2020-03-16,SARS-CoV-2 and COVID-19: The most important research questions,https://doi.org/10.1186/s13578-020-00404-4,Cell Biosci,,80000.0,,,,Other,,"In order to minimize the spreading of SARS-CoV-2, China has locked down Wuhan and nearby cities since January 23, 2020.","As of February 24, 2020, more than 80,000 confirmed cases including more than 2,700 deaths have been reported worldwide, affecting at least 37 countries.",RT-PCR-based SARS-CoV-2 RNA detection in respiratory samples provides the only specific diagnostic test at the initial phase of the outbreak.,2020-04-10
,2020-03-16,A Novel AI-enabled Framework to Diagnose Coronavirus COVID 19 using Smartphone Embedded Sensors: Design Study,https://doi.org/,ArXiv,,,,,,Other,,This leads to late detection and quarantine of infected people and less efficient treatment of patients .,This leads to late detection and quarantine of infected people and less efficient treatment of patients .,"Particularly, several techniques can be used to detect the initial results of the virus such as medical detection Kits.

Furthermore, medical detection kits are used to detect the COVID-19.

Despite NAT technique and detection kits becoming significant for COVID-19 virus detection, CT scan is most effective and functional for detecting the severity and degree of the lung inflammation .",2020-05-01
,2020-03-14,Accurate Identification of SARS-CoV-2 from Viral Genome Sequences using Deep Learning,https://doi.org/10.1101/2020.03.13.990242,biorxiv,,402.0,,,,Other,,"This resulted in 402 sequences, distributed as described in Table 2 .","This resulted in 402 sequences, distributed as described in Table 2 .","Molecular techniques, such as quantitative real-time RT-PCR and nucleic acid sequencing methods, are widely used to identify pathogens.",2020-04-10
,2020-03-14,High sensitivity detection of coronavirus SARS-CoV-2 using multiplex PCR and a multiplex-PCR-based metagenomic method,https://doi.org/10.1101/2020.03.12.988246,biorxiv,,,,,,Modeling,,"The plasmids containing either S or N gene of SARS-CoV-2 (pUC-S and pUC-N, respectively) were purchased from Sangon Biotech, Shanghai, China.","The two plasmids were diluted from approximately 9,000 copies to below one copy, and were amplified in multiplex PCR reactions.",AbstractMany detection methods have been used or reported for the diagnosis and/or surveillance of SARS-CoV-2.,2020-03-27
,2020-03-09,Sensitive one-step isothermal detection of pathogen-derived RNAs,https://doi.org/10.1101/2020.03.05.20031971,medrxiv,,175.0,,,,Other,,We then tested the orthogonal dual detection of two target 268 regions using the SARS-CoV-2-MG1 and SARS-CoV-2-BR2 probe pairs.,"Target RNA 175 sequences for SENSR are specified by only two hybridization regions (UHS and DHS) of 176 probes, which makes the probe design process fast and straightforward without many 177 All rights reserved.","Therefore, SENSR is more suitable for rapid 328 mass production of diagnostic kits than antibody-based diagnostics.

Immediate and 33 onsite diagnostic decisions also help to prevent the spread of epidemic and pandemic 34 infectious diseases In order to rapidly diagnose infectious diseases, a nucleic acid-based 35 diagnosis has emerged as an alternative to the conventional culture-based, or immunoassay-36 based, approaches due to their rapidity or specificity 4-6 .",2020-03-27
,2020-03-05,Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system,https://doi.org/10.2807/1560-7917.es.2020.25.9.2000152,Euro Surveill,,8.0,,,,Other,,All clinical specimens used were collected at the University Medical Center Hamburg-Eppendorf (UKE-HH).,"Limit of detection of the SARS-CoV-2 UCT was determined by analysing each of eight replicates of a dilution series containing IVT RNA diluted in E-swab medium (Copan, Brescia, Italy; modified liquid Amies medium) and Roche cobas PCR medium (1:1) at 10,000, 1,000, 500, 250 and 125 copies/mL and eight negative samples.",Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system,2020-03-27
,2020-03-04,Middle East respiratory syndrome,https://doi.org/10.1016/s0140-6736(19)33221-0,Lancet,,13.0,,,,Other,," We searched publications in the English language literature on PubMed and Google Scholar (dates we used to refine our search: Sept 1, 2012, to Dec 31, 2019).","In the 2015 Korean outbreak, three of 13 patients with MERS with respiratory failure were given four infusions of convalescent plasma.107 Two of three showed neutralising activity.","An updated roadmap for MERS-CoV product development lists all available diagnostics and other diagnostics in the developmental phase.84 Several diagnostic tests are under development to accelerate turnaround times from sample analysis to result.85, 86, 87 A 2018 rapid and specific assay for the detection of MERS-CoV combines the reverse transcription loop-mediated isothermal amplification technique and a vertical flow visualisation strip (RT-LAMP-VF) to detect the nucleocapsid gene of MERS-CoV.86 The RT-LAMP-VF assay provides detection of MERS-CoV within 35 min and is easier to perform than the WHO-recommended rRT-PCR method.86",2020-05-12
,2020-03-04,Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks,https://doi.org/10.3390/pathogens9030186,Pathogens,,9.0,,,,Other,,The first cases of SARS-CoV-2 infections were reported in the Chinese city of Wuhan during December 2019 .,"In a very recent study, the genomes of CoVs isolated from nine patients having viral pneumonia in Wuhan were analyzed .",The current diagnostic test for the virus is PCR-based .,2020-05-12
,2020-03-03,The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China,https://doi.org/10.1016/j.jaut.2020.102434,Journal of Autoimmunity,,70.0,,,,Modeling,,"Their study reported the clinical features of the first 41 patients admitted to the designated hospital in Wuhan who were laboratory-confirmed COVID-19 by January 2, 2020.","In Chen's study , 70 patients were given antibiotic treatment, among whom 25 patients were treated with a single antibiotic and 45 patients were given combination therapy.","Sampling techniques, extraction and detection of viral nucleic acids, and diagnostic reagents may affect the test results.

Several rapid and sensitive detection tests have been developed for the prevention and control of the SARS-CoV-2 outbreak.",2020-03-27
,2020-02-27,Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis,https://doi.org/10.1002/jmv.25727,Journal of Medical Virology,,128.0,,,,Other,,"In addition, we evaluated clinical diagnosis results obtained from different types of venous and fingerstick blood samples.",The clinical detection sensitivity and specificity of this test were measured using blood samples collected from 397 PCR confirmed COVID-19 patients and 128 negative patients at 8 different clinical sites.,"Although the virus (SARS-Cov-2) nucleic acid RT-PCR test has become the standard method for diagnosis of SARS-CoV-2 infection, these real-time PCR test kits have many limitations.",2020-03-27
,2020-02-20,The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future,https://doi.org/10.1016/j.micinf.2020.02.002,Microbes Infect,,4.0,,,,Other,,"Until February 6, 2020, confirmed 2019-nCoV pneumonia cases were increasing with worrisome speed in China.",Four other suspected patients were being examined.,"Conventional diagnostic testing methods, such as the assays for detection of antiviral antibodies or viral antigens have been developed and used clinically.

New diagnostic strategies including multiplex nucleic acid amplification and microarray-based assays may help in epidemiologic monitoring, along with taking effective prevention steps .",2020-04-24
,2020-02-13,"Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020",https://doi.org/10.2807/1560-7917.es.2020.25.6.2000082,Euro Surveill,,,,,,Other,,"a Of the initial 41 people who were hospitalised in Wuhan by 2 January 2020 with pneumonia due to a confirmed 2019-nCoV infection, 27 had an epidemiological link to the Huanan market .","In total, the data provided by 47 laboratories in 30 EU/EEA countries were taken into account in this study.","Challenges reported by laboratories in terms of implementing molecular diagnostics for novel coronavirus (2019-nCoV), EU/EEA, January 2020 (n = 47)",2020-03-27
,2020-02-04,A precision medicine approach to managing 2019 novel coronavirus pneumonia,https://doi.org/10.1093/pcmedi/pbaa002,Precis Clin Med,,7000.0,,,,Other,,"The National Health Commission issued a guidance on 27 January 2020, to remind medical institutions of the importance of chest CT and pathogen detection in diagnosing the virus.","As of 29 January 2020, the virus had been diagnosed in more than 7000 patients in China and 77 patients in other countries.","10 Currently, the most common diagnostic method of coronaviruses is molecular detection.

Currently, the most common diagnostic method of coronaviruses is molecular detection.10 A precision medicine approach is crucial to quickly confirm the diagnosis with laboratory methods, control the spread of the virus, and better allocate hospital resources.",2020-03-27
0,2020-04-23,Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients.,https://jcm.asm.org/content/jcm/early/2020/04/23/JCM.00798-20.full.pdf,American Society for Microbiology,Isothermal amplification,524 (paired),-,5-13 mins,,Clinical trial,2020-04-25,,,,
1,2020-04-17,The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays,https://jcm.asm.org/content/jcm/early/2020/04/17/JCM.00772-20.full.pdf,Journal of Clinical Microbiology,Roche cobas SARS-CoV-2 assay,103,Cepheid Xpert Xpress SARS-CoV-2 and Roche63 cobas SARS-CoV-2 assays show excellent agreement (>99%), Roche 3 hr 45 min,Y,Clinical Study,2020-04-23,,,,
2,2020-04-17,RAPID SEROLOGICAL TESTS HAVE A ROLE IN ASYMPTOMATIC HEALTH WORKERS COVID-19 SCREENING,https://www.medrxiv.org/content/10.1101/2020.04.15.20057786v1.full.pdf,medRxiv,rapid serological test Viva-Diag analyzingCOVID-19 associated-IgG/IgM.,512,"Viva-Diag is able to evidence subjects positive for IgM expression. However, discordant results with respect to rt-PCR and CLIA assays clearly refer to further studies to optimize the utilization of the serological test in asymptomatic and in at risk subjects.",-,?,Clinical Trial,2020-05-09,,,,
3,2020-04-16,Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.,https://www.ncbi.nlm.nih.gov/pubmed/32298139,Arch Pathol Lab Med,RT-PCR,136 studies,-,PCR: 2-6 Hours; LAMP N/A; Serology N/A,Y,Review,2020-04-25,,,,
4,2020-04-15,Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172500/,American Chemical Society Public Health Emergency Collection,COVID-19 FET sensor,3,The FET sensor responded to patient samples diluted as much as 1:1 × 105 (242 copies/mL),>1 minute,N,Simulation Study,2020-04-25,,,,
5,2020-04-13,Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.,https://www.ncbi.nlm.nih.gov/pubmed/32282894,Annals of Internal Medicine,"RT-PCR, Serology",-,-,>1 Hour NAAT (PCR),Y,Review,2020-04-25,,,,
6,2020-04-13,Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.,https://www.ncbi.nlm.nih.gov/pubmed/32282894,Annals of Internal Medicine,Serology ,-,-,-,Y,Review,,,,,
7,2020-04-13,Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.,https://www.ncbi.nlm.nih.gov/pubmed/32282894,Annals of Internal Medicine,Antigen Detection test,-,-,>1 Hour,Y,Review,,,,,
8,2020-04-13,Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.,https://www.ncbi.nlm.nih.gov/pubmed/32282894,Annals of Internal Medicine,CT,-,-,-,Y,Review,,,,,
9,2020-04-10,Point‐of‐care lung ultrasound in patients with COVID‐19 – a narrative review,https://onlinelibrary.wiley.com/doi/abs/10.1111/anae.15082,Assocaition of anesthesia ,Ultrasound,11 studies,-,Real Time ,Y,Review,2020-04-25,,,,
10,2020-04-03,COVID-19 pneumonia: A review of typical CT findings and differential diagnosis,https://www.sciencedirect.com/science/article/pii/S2211568420300917?via%3Dihub,Diagnostic and Interventional Imaging,CT,1014,"A large series based on 1014 patients reported a 97% sensitivity of chest CT for the diagnosis of COVID-19, while the mean time interval between initial negative and positive RT-PCR was approximately 5 days .",Hours,Y,Retrospective Cohort,2020-04-25,,,,
11,2020-04-03,The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges,https://jcm.asm.org/content/early/2020/04/03/JCM.00512-20.long,Journal of Clinical Microbiology,RT-PCR,426,-,-,Y,Review,2020-04-25,,,,
12,2020-04-03,The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges,https://jcm.asm.org/content/early/2020/04/03/JCM.00512-20.long,Journal of Clinical Microbiology,Rapid antigen test ,426,-,-,Y,Review,,,,,
13,2020-04-03,The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges,https://jcm.asm.org/content/early/2020/04/03/JCM.00512-20.long,Journal of Clinical Microbiology,Serology ,426,-,-,Y,Review,,,,,
14,2020-03-30,Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR,https://www.medrxiv.org/content/10.1101/2020.03.14.20036129v2,medRxiv,RT-dPCR,194,"The overall sensitivity, specificity and diagnostic accuracy of RT-dPCR were 90%, 100% and 93 %, respectively",<24 hrs,Y,Retrospective Cohort,2020-04-25,,,,
15,2020-03-30,Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department,https://onlinelibrary-wiley-com.ezp-prod1.hul.harvard.edu/doi/full/10.1002/jmv.25800,Journal of Medical Virology,VivaDiag COVID-19 IgM / IgG Rapid Test lateral flow immunoassay (LFIA),110,This study states that VivaDiag COVID‐19 IgM/IgG Rapid Test lateral flow immunoassay (LFIA) should not be used for diagnosis of COVID‐19 (n=110) since the test demonstrated poor sensitivty as measured by concomitant RT-PCR testing.,15 mins,?,Clinical trial,2020-04-25,,,,
16,2020-03-30,"SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge",https://www.medrxiv.org/content/10.1101/2020.03.24.20042689v1,medRxiv,RT-PCR,36,The lower limit of detection of the optimize dPCR is at least 10-fold lower than that of RT-PCR. The overall accuracy of dPCR for clinical detection is 96.3%,-,Y,Clinical Trial ,2020-05-09,,,,
17,2020-03-30,"SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge",https://www.medrxiv.org/content/10.1101/2020.03.24.20042689v2,medRxiv,dPCR,36,The lower limit of detection of the optimize dPCR is at least 10-fold lower than that of RT-PCR. The overall accuracy of dPCR for clinical detection is 96.3%,-,Y,Clinical Trial ,,,,,
18,2020-03-26,"Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19",https://mbio.asm.org/content/11/2/e00722-20.abstract,American society of microbiology,RT-PCR,-,-,-,Y,Review,2020-04-25,,,,
19,2020-03-26,"Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19",https://mbio.asm.org/content/11/2/e00722-20.abstract,American society of microbiology,Serology,-,-,7-11 days postexposure to virus,,Review,,,,,
20,2020-03-14,"Coronavirus disease 2019, whart we know : Review",https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25766,Journal of medical viriology ,RT-PCR,866,The positive rate of RT‐PCR for throat swab samples was reported to be about 60% in early stage of COVID‐19. CT in suspected patients was 97% based on positive RT‐PCR result and 75% based on negative RT‐PCR results,-,Y,Review,2020-04-25,,,,
21,2020-03-14,"Coronavirus disease 2019, whart we know : Review",https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25766,Journal of medical viriology ,CT,866,-,-,Y,Review,,,,,
22,2020-03-11,2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142866/,Micromachines,rRT-PCR,-,"rRT-PCR Diagnostic sensitivity of 95%, Sensitivity of Serology 88.66%", PCR 2-3 days;,Y,Review ,2020-04-25,,,,
23,2020-03-11,2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142866/,Micromachines,RT-LAMP,-,RT-LAMP Sensitivity >95%,RT-LAMP <1 hr,Y,Review ,,,,,
24,2020-03-11,2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142866/,Micromachines,Serology ,-,Serology Sensitivity 88.66%,,Y,Review ,,,,,
25,2020-03-06,Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing medrxiv,https://www.medrxiv.org/content/10.1101/2020.03.04.20030916v2,medRxiv,Serology (IgM & IgG Ab Eval),736,"IgM & IgG Sensitivity of 100%, Specificity of ~98%",>4 hrs,Y,Retrospective Cohort ,2020-04-25,,,,
26,2020-03-05,Molecular immune pathogenesis and diagnosis of COVID-19,https://covid19search.azurewebsites.net/home/document?docid=34e2f834075da481cda9ff4d8810fcba05abd96e&query=[{%22value%22:%22Diagnostic%20COVID-19%22}],Clinical Radiology,RT-PCR,5,"RT-qPCR can only achieve a sensitivity of 50% to 79%, depending on the protocol used the sample type and number of clinical specimens collected.  ",-,Y,Systematic Review,2020-04-25,,,,
27,2020-03-05,Molecular immune pathogenesis and diagnosis of COVID-19,https://covid19search.azurewebsites.net/home/document?docid=34e2f834075da481cda9ff4d8810fcba05abd96e&query=[{%22value%22:%22Diagnostic%20COVID-19%22}],Clinical Radiology,ELISA,5,The sensitivity of SARS-CoV N-based IgG ELISA (94.7%) is significantly higher than that of SARS-CoV S-based IgG ELISA (58.9%).The sensitivity of SARS-CoV-2 IgG/IgM remains to be studied.,-,Y,Systematic Review,,,,,
28,2020-03-05,Molecular immune pathogenesis and diagnosis of COVID-19,https://covid19search.azurewebsites.net/home/document?docid=34e2f834075da481cda9ff4d8810fcba05abd96e&query=[{%22value%22:%22Diagnostic%20COVID-19%22}],Clinical Radiology,HTS,5,-,-,Y,Systematic Review,,,,,
29,2020-03-03,Clinical significance of IgM and IgG test for diagnosis of highly suspected COVID-19 infection medrxiv,https://doi.org/10.1101/2020.02.28.20029025,medRxiv,Serology (IgM & IgG Ab Eval),57,The positive detection rate of combination of IgM and IgG for patients with COVID-19 negative and positive nucleic acid test was 72.73% and 87.50%.,-,Y,Prospective Cohort ,2020-04-25,,,,
30,2020-03-02,Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area,https://covid19search.azurewebsites.net/home/document?docid=ac80b578181504b29f62b712b8be899394e284d6&query=[{%22value%22:%22Diagnostic%20COVID-19%22}],Clinical Radiology,Spiral CT,114,"Rate of the CT examination in the diagnosis of SARS-CoV-2 infection was only 76.4%. Only three cases (2.6%) in this study showed no apparent abnormalities in the lungs at the initial CT examination, and the overall accuracy rate of CT examination in the present study was 97.3%",Hours,Y,Retrospective Cohort Study,2020-04-25,,,,
31,2020-03-01,Recent advances and perspectives of nucleic acid detection for coronavirus,https://www.sciencedirect.com/science/article/pii/S2095177920302082?via%3Dihub,Journal of Pharmaceutical Analysis,RT-PCR,-,"High Sensitivity and Specificity of RT-PCR; RT-LAMP, Microarray and CRISPR are analagous",-,Y,Review ,2020-04-25,,,,
32,2020-03-01,Recent advances and perspectives of nucleic acid detection for coronavirus,https://www.sciencedirect.com/science/article/pii/S2095177920302082?via%3Dihub,Journal of Pharmaceutical Analysis,RT-LAMP,-,"High Sensitivity and Specificity of RT-PCR; RT-LAMP, Microarray and CRISPR are analagous",RT-LAMP> 1hr,Y,Review ,,,,,
33,2020-03-01,Recent advances and perspectives of nucleic acid detection for coronavirus,https://www.sciencedirect.com/science/article/pii/S2095177920302082?via%3Dihub,Journal of Pharmaceutical Analysis,CRISPR,-,"High Sensitivity and Specificity of RT-PCR; RT-LAMP, Microarray and CRISPR are analagous",,Y,Review ,,,,,
34,2020-03-01,Recent advances and perspectives of nucleic acid detection for coronavirus,https://www.sciencedirect.com/science/article/pii/S2095177920302082?via%3Dihub,Journal of Pharmaceutical Analysis,Microarray,-,"High Sensitivity and Specificity of RT-PCR; RT-LAMP, Microarray and CRISPR are analagous",,Y,Review ,,,,,
35,2020-02-29,Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP medrxiv,https://www.medrxiv.org/content/10.1101/2020.02.26.20028373v1,medRxiv,RT-LAMP,19,"Colorimetric LAMP assay showed 100% agreement with the RT-qPCR results across a range of Cq values,",~40 mins,Y,Simulation Study,2020-04-25,,,,
36,2020-02-29,Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP medrxiv,https://www.medrxiv.org/content/10.1101/2020.02.26.20028373v1,medRxiv,mNGS,19,"Colorimetric LAMP assay showed 100% agreement with the RT-qPCR results across a range of Cq values,",~40 mins,Y,Simulation Study,,,,,
37,2020-02-29,Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP medrxiv,https://www.medrxiv.org/content/10.1101/2020.02.26.20028373v1,medRxiv,rRT-PCR,19,"Colorimetric LAMP assay showed 100% agreement with the RT-qPCR results across a range of Cq values,",~40 mins,Y,Simulation Study,,,,,
38,2020-02-27,Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25727,Journal of medical viriology ,Serology,525,"the IgG‐IgM combined antibody test kit, has a sensitivity of 88.66% and specificity of 90.63%.",<15 minutes,?,Clinical trial,2020-04-25,,,,
39,2020-02-27,"Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020 Euro Surveill",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055037/,Eurosurveillance,rRT-PCR kit (QIAStat-Dx Respiratory Panel),126,"Broad screening for respiratory pathogens revealed a high rate of influenza virus infections, accounting for 28.5% of all suspected cases of SARS-CoV-2 infection.",-,Y,Retrospective Cohort Study,2020-04-25,,,,
40,2020-2-26,Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?,https://www.ejradiology.com/article/S0720-048X(20)30150-9/pdf,European Journal of Radiology,CT,36,Sensitivity of CT examinations was 97.2% at presentation, CT <5 hours,Y,Retrospective Cohort,2020-04-25,,,,
41,2020-2-26,Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?,https://www.ejradiology.com/article/S0720-048X(20)30150-9/pdf,European Journal of Radiology,rRT-PCR,36,first round rRT-PCR sensitivity was 84.6%,RT-PCR 5-6 hrs,Y,Retrospective Cohort,,,,,
42,2020-02-26,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141113/,Journal of Clinical Medicine,RT-PCR,16 studies," RT-PCR: 52.2%, 78.7%, 74.5%, and 58.1%.",-,Y,Review,2020-04-25,,,,
43,2020-02-26,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141113/,Journal of Clinical Medicine,RT-LAMP,16 studies," RT-LAMP was also able to detect viral RNA at levels as low as 0.7 copies, showing equivalence with the RT-PCR assay.",,Y,Review,,,,,
44,2020-02-26,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141113/,Journal of Clinical Medicine,RT-iiPCR;,16 studies,"Overall agreement between RT-iiPCR assays and reference RT-qPCR assays for sensitivity, specificity, positive predictive value, and negative predictive value of the test were  98.06% (95% CI, 94.43–100%) and 99.03% (95% CI, 95.88–100%) for ORF1a and upE assays, respectively. ",,Y,Review,,,,,
45,2020-02-26,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141113/,Journal of Clinical Medicine,One Step rRT-PCR,16 studies,"Overall agreement between RT-iiPCR assays and reference RT-qPCR assays for sensitivity, specificity, positive predictive value, and negative predictive value of the test were  98.06% (95% CI, 94.43–100%) and 99.03% (95% CI, 95.88–100%) for ORF1a and upE assays, respectively. ",,Y,Review,,,,,
46,2020-02-26,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141113/,Journal of Clinical Medicine,ELISA,16 studies,"Sensitivity, Specificity, positive predictive value, and negative predictive value of the test were ELISA: 98.2%, 98.7%, 98.7%,  and 98.4%",,Y,Review,,,,,
47,2020-02-25,"SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.",https://www.medrxiv.org/content/medrxiv/early/2020/02/25/2020.02.21.20026179.full.pdf,MedRxIV,RT-PCR,9,"RT-PCR was used to detect SARS-CoV-2 RNA in urine and blood specimens, and anal and oropharyngeal swabs (n=9)",-,N,Clinical trial,2020-04-25,,,,
48,2020-02-25,Laboratory diagnosis of emerging human coronavirus infections – the state of the art,https://www.ncbi.nlm.nih.gov/pubmed/32196430,Emerging Microbes & Infections ,Antigen EIA; ,406,"Rapid, poor sensitivity, some are CLIA-waived; Good sensitivity and specificity, subjective interpretation; Gold standard, pure culture for further research and development, time consuming; Retrospective, cross-reaction; ; High sensitivity and specificity for special species, potential quantification; High sensitivity and specificity, covering other pathogens, FilmArray RP EZ is CLIA-waived; Rapid and safe, good sensitivity and specificity, some are CLIA-waived",<30 min; ,Y,Systematic Review,2020-04-25,,,,
49,2020-02-25,Laboratory diagnosis of emerging human coronavirus infections – the state of the art,https://www.ncbi.nlm.nih.gov/pubmed/32196430,Emerging Microbes & Infections ,Antigen IFA,406,"Rapid, poor sensitivity, some are CLIA-waived; Good sensitivity and specificity, subjective interpretation; Gold standard, pure culture for further research and development, time consuming; Retrospective, cross-reaction; ; High sensitivity and specificity for special species, potential quantification; High sensitivity and specificity, covering other pathogens, FilmArray RP EZ is CLIA-waived; Rapid and safe, good sensitivity and specificity, some are CLIA-waived",1–4 h,Y,Systematic Review,,,,,
50,2020-02-25,Laboratory diagnosis of emerging human coronavirus infections – the state of the art,https://www.ncbi.nlm.nih.gov/pubmed/32196430,Emerging Microbes & Infections ,Cell culture,406,"Rapid, poor sensitivity, some are CLIA-waived; Good sensitivity and specificity, subjective interpretation; Gold standard, pure culture for further research and development, time consuming; Retrospective, cross-reaction; ; High sensitivity and specificity for special species, potential quantification; High sensitivity and specificity, covering other pathogens, FilmArray RP EZ is CLIA-waived; Rapid and safe, good sensitivity and specificity, some are CLIA-waived",1–7 days,Y,Systematic Review,,,,,
51,2020-02-25,Laboratory diagnosis of emerging human coronavirus infections – the state of the art,https://www.ncbi.nlm.nih.gov/pubmed/32196430,Emerging Microbes & Infections ,Serology,406,"Rapid, poor sensitivity, some are CLIA-waived; Good sensitivity and specificity, subjective interpretation; Gold standard, pure culture for further research and development, time consuming; Retrospective, cross-reaction; ; High sensitivity and specificity for special species, potential quantification; High sensitivity and specificity, covering other pathogens, FilmArray RP EZ is CLIA-waived; Rapid and safe, good sensitivity and specificity, some are CLIA-waived",2–8 h,Y,Systematic Review,,,,,
52,2020-02-25,Laboratory diagnosis of emerging human coronavirus infections – the state of the art,https://www.ncbi.nlm.nih.gov/pubmed/32196430,Emerging Microbes & Infections ,NAAT (PCR),406,"Rapid, poor sensitivity, some are CLIA-waived; Good sensitivity and specificity, subjective interpretation; Gold standard, pure culture for further research and development, time consuming; Retrospective, cross-reaction; ; High sensitivity and specificity for special species, potential quantification; High sensitivity and specificity, covering other pathogens, FilmArray RP EZ is CLIA-waived; Rapid and safe, good sensitivity and specificity, some are CLIA-waived",1–8 h,Y,Systematic Review,,,,,
53,2020-02-25,Laboratory diagnosis of emerging human coronavirus infections – the state of the art,https://www.ncbi.nlm.nih.gov/pubmed/32196430,Emerging Microbes & Infections ,monoplex,406,"Rapid, poor sensitivity, some are CLIA-waived; Good sensitivity and specificity, subjective interpretation; Gold standard, pure culture for further research and development, time consuming; Retrospective, cross-reaction; ; High sensitivity and specificity for special species, potential quantification; High sensitivity and specificity, covering other pathogens, FilmArray RP EZ is CLIA-waived; Rapid and safe, good sensitivity and specificity, some are CLIA-waived",1–8 h,Y,Systematic Review,,,,,
54,2020-02-25,Laboratory diagnosis of emerging human coronavirus infections – the state of the art,https://www.ncbi.nlm.nih.gov/pubmed/32196430,Emerging Microbes & Infections ,pan-HCoV,406,High sensitivity with universal coverage of all species of HCoV,1–8 h,Y,Systematic Review,,,,,
55,2020-02-25,Laboratory diagnosis of emerging human coronavirus infections – the state of the art,https://www.ncbi.nlm.nih.gov/pubmed/32196430,Emerging Microbes & Infections ,specific-HCoV,406,High sensitivity with universal coverage of all species of HCoV,15-30 min,Y,Systematic Review,,,,,
56,2020-02-25,Laboratory diagnosis of emerging human coronavirus infections – the state of the art,https://www.ncbi.nlm.nih.gov/pubmed/32196430,Emerging Microbes & Infections ,multiplex,406,"Rapid, poor sensitivity, some are CLIA-waived; Good sensitivity and specificity, subjective interpretation; Gold standard, pure culture for further research and development, time consuming; Retrospective, cross-reaction; ; High sensitivity and specificity for special species, potential quantification; High sensitivity and specificity, covering other pathogens, FilmArray RP EZ is CLIA-waived; Rapid and safe, good sensitivity and specificity, some are CLIA-waived",,,,,,,,
57,2020-02-24,Rapid colorimetric detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform: iLACO,https://www.medrxiv.org/content/10.1101/2020.02.20.20025874v1,medRxiv,iLAMP,43,"iLACO is very sensitive, and as low as 10 copies of ORF1ab gene were detected successfully.",2-3 hours,Y,Simulation,2020-0425,,,,
58,2020-02-24,Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription-Loop-Mediated Isothermal Amplification,https://www.medrxiv.org/content/10.1101/2020.02.19.20025155v1,medRxiv,RT-LAMP,,RT-LAMP is specific and sensitive for COVID-19 (unspecified),RT-LAMP <30mins,Y,Simulation,2020-04-25,,,,
59,2020-02-24,Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription-Loop-Mediated Isothermal Amplification,https://www.medrxiv.org/content/10.1101/2020.02.19.20025155v2,medRxiv,RT-PCR,,RT-PCR has high sensitivity and specificity,RT-LAMP <30mins,Y,Simulation,2020-04-25,,,,
60,2020-02-23,Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2) infected pneumonia (COVID-19),https://www.medrxiv.org/content/10.1101/2020.02.21.20026187v1.article-info,medRxiv,rRT-PCR,54,"The positive rates of 2019-nCoV from sputum specimens and throat swabs 12 were 76.9% and 44.2%, respectively. Sputum specimens showed a significantly 13 higher positive rate than throat swabs in detecting viral nucleic acid using qRT-PCR 14 assay (P=0.001).",1-2 hours,Y,Retrospective Cohort,"43,946",,,,
61,2020-02-19,"2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China Journal of Microbiology, Immunology and Infection",https://www.sciencedirect.com/science/article/pii/S1684118220300372?via%3Dihub,"Journal of Microbiology, Immunology and Infection",RT-PCR ,2,-,Hours,Y,Case Report,"43,946",,,,
62,2020-02-19,"2020 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China Journal of Microbiology, Immunology and Infection",https://www.sciencedirect.com/science/article/pii/S1684118220300372?via%3Dihub,"Journal of Microbiology, Immunology and Infection",CXR,2,-,an hour,Y,Case Report,,,,,
63,2/16/2020,"A  Single and Two-Stage, Closed-Tube, Molecular Test for the 2019  Novel Coronavirus (COVID-19)at Home, Clinic, and Points of Entry",https://chemrxiv.org/articles/A_Single_and_Two-Stage_Closed-Tube_Molecular_Test_for_the_2019_Novel_Coronavirus_COVID-19_at_Home_Clinic_and_Points_of_Entry/11860137,ChemRxiv,RT-LAMP,-,COVID-19 LAMP and COVID-19 PCR provided 100% sensitivity at 700 viral particles per reaction and 75% sensitivity at 70 viral copies per reaction. ,<1 Hour,N,Proof of concept,2020-04-25,,,,
64,2/16/2020,"A  Single and Two-Stage, Closed-Tube, Molecular Test for the 2019  Novel Coronavirus (COVID-19)at Home, Clinic, and Points of Entry",https://chemrxiv.org/articles/A_Single_and_Two-Stage_Closed-Tube_Molecular_Test_for_the_2019_Novel_Coronavirus_COVID-19_at_Home_Clinic_and_Points_of_Entry/11860138,ChemRxiv,Penn-RAMP,-,COVID-19 Closed-Tube Penn-RAMP provided 100% Sensitivity,<1 Hour,N,Proof of concept,,,,,
65,2/16/2020,"A  Single and Two-Stage, Closed-Tube, Molecular Test for the 2019  Novel Coronavirus (COVID-19)at Home, Clinic, and Points of Entry",https://chemrxiv.org/articles/A_Single_and_Two-Stage_Closed-Tube_Molecular_Test_for_the_2019_Novel_Coronavirus_COVID-19_at_Home_Clinic_and_Points_of_Entry/11860139,ChemRxiv,RT-PCR,-,COVID-19 LAMP and COVID-19 PCR provided 100% sensitivity at 700 viral particles per reaction and 75% sensitivity at 70 viral copies per reaction,<1 Hour,N,Proof of concept,,,,,
66,2020-02-13,Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan medrxiv,https://www.medrxiv.org/content/10.1101/2020.02.12.20022327v2,medRxiv,rRT-PCR,8274,-,< 24 hrs,Y,Retrospective Cohort Study ,2020-04-25,,,,
67,2020-02-04,Recent advances in the detection of respiratory virus infection in humans Journal of Medical Virology,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25674,Journal of Medical Virology,RT-PCR ,-,"Sensitivity and specificity of rRT‐PCR kits for detecting upE and ORF1a reach 100% (95% confidence interval [CI], 0.60‐1.00) and 100% (95% CI, 0.79‐1.00), respectively.",-,Y,Systematic Review,2020-04-25,,,,
68,2020-02-04,Recent advances in the detection of respiratory virus infection in humans Journal of Medical Virology,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25674,Journal of Medical Virology,rRT-PCR,-,"Sensitivity and specificity of rRT‐PCR kits for detecting upE and ORF1a reach 100% (95% confidence interval [CI], 0.60‐1.00) and 100% (95% CI, 0.79‐1.00), respectively.",-,Y,Systematic Review,,,,,
69,2020-02-04,Recent advances in the detection of respiratory virus infection in humans Journal of Medical Virology,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25674,Journal of Medical Virology,"RT-LAMP,",-,"The RT‐LAMP‐VF assay can detect 2 × 101 copies/μL of synthesized RNA transcript and 1 × 101 copies/μL of MERS‐CoV RNA without cross‐reactivity to multiple SARS‐related‐CoVs, including HKU1, HKU4, OC43 and 229E, thus exhibiting high specificity.",RT-LAMP <20 mins,Y,Systematic Review,,,,,
70,2020-02-04,Recent advances in the detection of respiratory virus infection in humans Journal of Medical Virology,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25674,Journal of Medical Virology,"RT-LAMP,",-,"The RT‐LAMP‐VF assay can detect 2 × 101 copies/μL of synthesized RNA transcript and 1 × 101 copies/μL of MERS‐CoV RNA without cross‐reactivity to multiple SARS‐related‐CoVs, including HKU1, HKU4, OC43 and 229E, thus exhibiting high specificity.",RT-LAMP <20 mins,Y,Systematic Review,,,,,
71,2020-01-31,Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia,https://academic.oup.com/clinchem/article/66/4/549/5719336,Clinical Chemistry,One step RT-PCR,2,"The amplification efficiencies of ORF1b and N gene assays were 99.6% and 95.4%, respectively (R2 > 0.99 in both cases).",75 mins,N,Simlation Study,2020-04-23,,,,
72,2020-01-22,Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988269/,Eurosurveillance,RT-PCR,297,"All assays were highly sensitive, with best results obtained for the E gene and RdRp gene assays (5.2 and 3.8 copies per reaction at 95% detection probability, respectively).",2.5 hr,Y,Retrospective Cohort,2020-04-23,,,,
73,Unknown,The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays,https://jcm.asm.org/content/jcm/early/2020/04/17/JCM.00772-20.full.pdf,Journal of Clinical Microbiology,Cepheid Xpert Xpress SARS-CoV-2 assay,103,Cepheid Xpert Xpress SARS-CoV-2 and Roche63 cobas SARS-CoV-2 assays show excellent agreement (>99%),45 mins,Y ,Clinical Study,2020-04-23,,,,
74,Unknown,The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays,https://jcm.asm.org/content/jcm/early/2020/04/17/JCM.00772-20.full.pdf,Journal of Clinical Microbiology,,,,,,,,,,,
75,Unknown,Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.,https://www.ncbi.nlm.nih.gov/pubmed/32298139,Arch Pathol Lab Med,LAMP,136 studies,-,-,Y,Review,2020-04-25,,,,
76,Unknown,Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.,https://www.ncbi.nlm.nih.gov/pubmed/32298139,Arch Pathol Lab Med,Serology ,136 studies,-,-,Y,Review,2020-04-25,,,,
